Natalie Mesnier
Foot and Ankle Surgery · Portland, ORNPI 1346366523
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $267,287 of the $339,273 with a category attached, or 78.8%. Stryker accounts for 94.9% of it on its own, with 8 other manufacturers making up the rest. Among foot and ankle surgery clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 407 payments — averaging $833.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$322K
- Paragon 28, Inc.$13K
- Steelhead Surgical Inc$4K
- Galderma Laboratories, L.p.$138
- Treace Medical Concepts, Inc.$124
- Revance Therapeutics, Inc.$34
- plus $70 from 3 others
What the payments were for
- Consulting fees$267,28779%
- Travel & lodging$55,17316%
- Food & beverage$12,0014%
- Education$4,8131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 379 | $322,120 |
| Paragon 28, Inc. | 14 | $12,616 |
| Steelhead Surgical Inc | 6 | $4,172 |
| Galderma Laboratories, L.p. | 2 | $138 |
| Treace Medical Concepts, Inc. | 1 | $124 |
| Revance Therapeutics, Inc. | 2 | $34 |
| Bioventus LLC | 1 | $31 |
| Smith+Nephew | 1 | $22 |
| Ossur Americas, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$170,493
- PROPHECY$49,588
- INBONE$18,137
- EASY CLIP$18,000
- ORTHOLOC 2 LAPIFUSE$18,000
- EASYFUSE$18,000
- HOFFMANN$16,822
- INVISION$15,300
- INFINITY$12,866
- PROSTEP MICA$9,372
- Product Portfolio$6,806
- Portfolio$5,362
- OASYS$4,050
- PRIME SERIES$3,330
- AUGMENT INJECTABLE$2,685
- AXSOS$2,197
- VARIAX$2,197
- GAMMA$2,197
- SALVATION$668
- MIS Instrumentation$664
How this compares
$339,273 in reported general payments places this provider in the 95th percentile of 113 foot and ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 39 | $271 |
| Ondansetron Hcl | 15 | $154 |
| Gabapentin | 18 | $123 |
| Oxycodone Hcl | 14 | $88 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Portland
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Kevin DriscollPortland$21K
- John MassoudPortland$14K
- Kenneth HegewaldPortland$11K
- Steven LaxsonPortland$11K
- Lara AtwaterPortland$10K
- Denny lePortland$9K
- Andrew HuPortland$7K
- Paul JonesPortland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.